24.07.2019 • News

Clariant’s CEO Ernesto Occhiello Resigns

Ernesto Occhiello has resigned as CEO of Clariant with immediate effect....
Ernesto Occhiello has resigned as CEO of Clariant with immediate effect. Source: Clariant

Swiss chemicals major Clariant announced today that its CEO Ernesto Occhiello has resigned for personal reasons with immediate effect. Hariolf Kottmann, chairman of the company's board of directors, has assumed Occhiello's responsibilities in the interim as executive chairman.

Occhiello was appointed as CEO of Clariant in September 2018 following SABIC’s acquisition of a 24.99% stake in the Swiss company, announced in January 2018.

Clariant said that until further notice, Clariant’s Executive Committee will consist of Hariolf Kottmann, executive chairman, Patrick Jany, chief financial officer, and Hans Bohnen, chief operating officer. In order to comply with Swiss governance rules, Eveline Saupper has been appointed independent lead director of the board.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.